| Flumazenil Related Compound C (N,N-Dimethylformamide diethyl acetal) | Not available | C7H17NO2 |
| Flumequine Ethyl Ester | 42835-47-2 | C16H16FNO3 |
| Flumequine Imp. B (EP): Ethyl (RS)-9-Fluoro-5-methyl-1-oxo-6,7-dihydro- 1H,5H-benzo[i,j]quinolizine-2-carboxylate (Flumequine Ethyl Ester) | 42835-47-2 | C16H16FNO3 |
| Flumequine impurity B | 42835-47-2 | C16H16FNO3 |
| Flumetasone Pivalate Imp. A (EP): 6 ,9-Difluoro-11 ,17,21- trihydroxy-16 -methylpregna-1,4-diene- 3,20-dione (Flumetasone) | 2135-17-3 | C22H28F2O5 |
| Flunarizine | 52468-60-7 | C26H26F2N2 |
| Flunarizine dihydrochloride for system suitability | 30484-77-6 | C26H28Cl2F2N2 |
| Flunarizine Dihydrochloride Imp. A (EP): 1-[Bis(4-fluorophenyl)methyl]- piperazine | 27469-60-9 | C17H18F2N2 |
| Flunarizine EP Impurity A | 27469-60-9 | C17H18F2N2 |
| Flunarizine EP Impurity B | 39245-25-5 | C26H27FN2 |
| Flunarizine EP Impurity C | 90830-31-2 | C26H26F2N2 |
| Flunarizine EP Impurity D | 693765-11-6 | C26H26F2N2 |
| Flunarizine HCl | 30484-77-6 | C26H28Cl2F2N2 |
| Flunarizine Impurity | 365-22-0 | C13H11FO |
| Flunarizine Impurity 2 | 123375-94-0 | C26H26F2N2O |
| Flunarizine Impurity 6 | 88172-16-1 | C22H26N2 |
| Flunarizine Impurity 11 | 39199-93-4 | C9H9Cl |
| Flunarizine Impurity 12 | 14155-36-3 | C9H10Cl2 |
| Flunarizine Impurity 13 | 4510-34-3 | C9H10O |
| Flunarizine Impurity 15 (cis-Cinnamaldehyde) | 57194-69-1 | C9H8O |
| Flunarizine Impurity 16 | 144917-53-3 | C26H26F2N2O |
| Flunazepam EP impurity A | 894-76-8 | C15H12FN3O |
| Flunazepam impurity 1 | 735-06-8 | C14H11FN2O3 |
| Flunitrazepam EP Impurity B | 2558-30-7 | C15H10FN3O3 |
| Flunitrazepam EP Impurity C | 2512213-47-5 | C16H12FN3O3 |
| Flunitrazepam Imp. A (EP): 7-Amino-5-(2-fluorophenyl)- 1,3-dihydro-2H-1,4-benzodiazepin-2-one (7-Aminodemethylflunitrazepam) | 894-76-8 | C15H12FN3O |
| Flunitrazepam Imp. B (EP): 5-(2-Fluorophenyl)-7-nitro-1,3- dihydro-2H-1,4-benzodiazepin-2-one (Demethylflunitrazepam) | 2558-30-7 | C15H10FN3O3 |
| Flunitrazepam Impurity 3 | 344-80-9 | C13H9FN2O3 |
| Flunitrazepam Impurity 4 | 76895-80-2 | C15H10ClFN2O4 |
| Flunitrazepam Impurity 5 | 34084-50-9 | C16H14FN3O |
| Flunitrazepam Impurity 7 | 74892-39-0 | C17H14FN3O3 |
| Flunitrazepam Impurity 8 | 74723-10-7 | C15H10FN3O4 |
| Flunitrazepam Impurity 9 | 67739-71-3 | C16H12FN3O4 |
| Flunitrazepam Impurity 10 | 74723-07-2 | C17H14FN3O2 |
| Flunixin impurity B | 54396-44-0 | C8H8F3N |
| Flunixin impurity C | 1452-94-4 | C8H8ClNO2 |
| Flunixin Isopropyl Ester | Not available | C17H17F3N2O2 |
| Flunixin Meglumine EP Impurity A | 2942-59-8 | C6H4ClNO2 |
| Flunixin Meglumine EP Impurity B | 54396-44-0 | C8H8F3N |
| Flunixin Meglumine EP Impurity C | 1452-94-4 | C8H8ClNO2 |
| Flunixin Meglumine EP Impurity D | 54396-42-8 | C16H15F3N2O2 |
| Flunixin Meglumine Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid | 2942-59-8 | C6H4ClNO2 |
| Flunixin Meglumine Imp. B (EP): 2-Methyl-3-(trifluoromethyl)aniline | 54396-44-0 | C8H8F3N |
| Flunixin Meglumine Imp. C (EP): Ethyl 2-Chloropyridine-3-carboxylate | 1452-94-4 | C8H8ClNO2 |
| Flunixin Meglumine Imp. D (EP): Ethyl 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino] pyridine-3-carboxylate (Flunixin Ethyl Ester) | 54396-42-8 | C16H15F3N2O2 |
| Flunixin meglumine impurity 2 | 75369-63-0 | C15H13F3N2O2 |
| Flunixin meglumine impurity 4 | 23323-37-7 | C14H31NO5 |
| Flunixin Methyl Ester | 75369-63-0 | C15H13F3N2O2 |
| Flunixin Related Compound A | 2942-59-8 | C6H4ClNO2 |
| Flunixin Related Compound C | 1452-94-4 | C8H8ClNO2 |
| Fluocinolone acetate impurity 1 | 67438-37-3 | C26H32F2O7 |
| Fluocinolone Acetonide EP Impurity A (Fluocinolone Acetonide-21-Carboxylic Acid) | 106931-78-6 | C24H28F2O7 |
| Fluocinolone Acetonide EP Impurity B (Fluocinolone Acetonide-20-Carboxylic Acid) | 65751-34-0 | C23H28F2O6 |
| Fluocinolone Acetonide EP Impurity C (Fluocinolone) | 807-38-5 | C21H26F2O6 |
| Fluocinolone Acetonide EP Impurity D | 13242-30-3 | C24H28F2O6 |
| Fluocinolone Acetonide EP Impurity F | 1526-01-8 | C24H33FO5 |
| Fluocinolone Acetonide EP Impurity G | 2802-11-1 | C26H35FO7 |
| Fluocinolone Acetonide EP Impurity H (triamcinolone acetonide) | 76-25-5 | C24H31FO6 |
| Fluocinolone Acetonide EP Impurity I | Not available | C24H28F2O6 |
| Fluocinolone Acetonide EP Impurity K | Not available | C24H30F2O6 |
| Fluocinolone Acetonide EP Impurity L | 1893-65-8 | C24H30ClFO6 |
| Fluocinolone acetonide EP Impurity M | 356-12-7 | C26H32F2O7 |
| Fluocinolone acetonide for peak identification | 67-73-2 | C24H30F2O6 |
| Fluocinolone acetonide for system suitability | 67-73-2 | C24H30F2O6 |
| Fluocinolone Acetonide Impurity 10 | 1181-32-4 | C26H32ClFO7 |
| Fluocinolone Acetonide Impurity J | 1361531-95-4 | C24H30F2O6 |
| Fluocinolone impurity 16 | 1178-54-7 | C24H32F2O6 |
| Fluocortolone pivalate for ID and assay | 29205-06-9 | C27H37FO5 |
| Fluocortolone pivalate for ID and assay CRS | 29205-06-9 | C27H37FO5 |
| Fluocortolone pivalate for system suitability | 29205-06-9 | C27H37FO5 |
| Fluorescein impurity 1 | 2318-08-3 | C20H12O5 |
| Fluorescein impurity C | 2513-33-9 | C14H10O5 |
| Fluorescein Related Compound C | 2513-33-9 | C14H10O5 |
| Fluorescein Sodium Imp. A (EP): Resorcinol | 108-46-3 | C6H6O2 |
| Fluorescein Sodium Imp. B (EP): Benzene-1,2-dicarboxylic Acid (Phthalic Acid) | 88-99-3 | C8H6O4 |
| Fluorescein Sodium Imp. C (EP): 2-(2,4-Dihydroxybenzoyl)benzoic Acid | 2513-33-9 | C14H10O5 |
| Fluorescein Sodium Impurity 6 | 7262-41-1 | C22H14O6 |
| Fluorescent yellow dilithium salt | 67769-47-5 | C13H9Li2N5O9S2 |
| Fluorometholone Related Compound A | 6870-94-6 | C22H30O4 |
| fluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin- 2-yl)methyl]sulphinyl]-1-methyl-1H-benzimidazole 2-Chloromethyl-3,4-dimethoxypyridine | 721924-06-7 | C17H17F2N3O4S |
| fluorophenyl)-1,3-dihydro-2H-1,4- | 2886-65-9 | C15H10ClFN2O |
| Fluoroquinolonic acid | 86393-33-1 | C13H9ClFNO3 |
| Fluorouracil EP Impurity A | 67-52-7 | C4H4N2O3 |
| Fluorouracil EP Impurity B | 496-76-4 | C4H4N2O3 |
| Fluorouracil EP Impurity D | 6623-81-0 | C5H6N2O3 |
| Fluorouracil EP Impurity E | 1820-81-1 | C4H3ClN2O2 |
| Fluorouracil EP Impurity F | 56177-80-1 | C6H7FN2O2 |
| Fluorouracil EP Impurity G | 57-13-6 | CH4N2O |
| Fluorouracil Imp. A (EP): Pyrimidine-2,4,6-(1H,3H,5H)- trione (Barbituric Acid) | 67-52-7 | C4H4N2O3 |
| Fluorouracil Imp. B (EP): Dihydropyrimidine-2,4,5(3H)- trione (Isobarbituric Acid or 5-Hydroxyuracil) | 496-76-4 | C4H4N2O3 |
| Fluorouracil Imp. C (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil) | 66-22-8 | C4H4N2O2 |
| Fluorouracil Imp. D (EP): 5-Methoxypyrimidine-2,4(1H,3H)- dione (5-Methoxyuracil) | 6623-81-0 | C5H6N2O3 |
| Fluorouracil Imp. E (EP): 5-Chloropyrimidine-2,4(1H,3H)- | 1820-81-1 | C4H3ClN2O2 |
| Fluorouracil Impurity 4 | 1480-96-2 | C5H5FN2O2 |
| Fluorouracil impurity 6 | 58629-87-1 | C3H3FO3 |
| Fluorouracil impurity 10 | 2145-56-4 | C5H5F3N2O2 |
| Fluorouracil impurity 22 | 75500-02-6 | C18H15FN2O2 |
| Fluorouracil impurity A | 67-52-7 | C4H4N2O3 |
| Fluorouracil impurity B | 496-76-4 | C4H4N2O3 |
| Fluorouracil impurity C | 66-22-8 | C4H4N2O2 |
| Fluorouracil impurity F | 56177-80-1 | C6H7FN2O2 |
| Fluorouracil Related Compound A | 67-52-7 | C4H4N2O3 |
| Fluorouracil Related Compound A (Pyrimidine-2,4,6(1H,3H,5H)-trione) | Not available | C4H4N2O3 |
| Fluorouracil Related Compound B | 496-76-4 | C4H4N2O3 |
| Fluorouracil Related Compound B (Dihydropyrimidine-2,4,5(3H)-trione) | Not available | C4H4N2O3 |
| Fluorouracil Related Compound E | 1820-81-1 | C4H3ClN2O2 |
| Fluorouracil Related Compound F | 56177-80-1 | C6H7FN2O2 |
| Fluoxetine (Hydrochloride) | 56296-78-7 | C17H19ClF3NO |
| Fluoxetine EP Impurity B | 23580-89-4 | C10H15N |
| Fluoxetine EP Impurity B (Hydrochloride) | 30684-07-2 | C10H16ClN |
| Fluoxetine EP Impurity C | 56161-72-9 | C17H18F3NO |
| Fluoxetine EP Impurity C (Hydrochloride) | 79088-29-2 | C17H19ClF3NO |
| Fluoxetine EP Impurity E | 97145-88-5 | C4H11Cl2N |
| Fluoxetine EP Impurity G | 885101-12-2 | C18H21ClF3NO |
| Fluoxetine EP Impurity H | 57226-68-3 | C16H17ClF3NO |
| Fluoxetine Hydrochloride Imp. A (EP): (1RS)-3-(Methylamino)-1- phenylpropan-1-ol | 42142-52-9 | C10H15NO |
| Fluoxetine Hydrochloride Imp. B (EP) as Hydrochloride: N-Methyl-3- phenylpropan-1-amine Hydrochloride (Methyl-3-phenylpropylamine Hydrochloride) | 30684-07-2 | C10H16ClN |
| Fluoxetine Impurity 1 (Hydrochloride) | 2243504-22-3 | C17H19ClF3NO |
| Fluoxetine impurity 6 | 83891-03-6 | C16H16F3NO |
| Fluoxetine impurity 7 | 1026723-45-4 | C21H22F3NO4 |
| Fluoxetine Impurity 7 | 402-45-9 | C7H5F3O |
| Fluoxetine impurity 8 | 310452-35-8 | C24H21F6NO |
| Fluoxetine impurity 9 | 175359-21-4 | C7H4F2O |
| Fluoxetine impurity 13 | 352-12-5 | C7H6ClF |
| Fluoxetine impurity 15 | 3506-36-3 | C11H15NO |
| Fluoxetine impurity A | 42142-52-9 | C10H15NO |
| Fluoxetine impurity A CRS | 42142-52-9 | C10H15NO |
| Fluoxetine impurity B | 23580-89-4 | C10H15N |
| Fluoxetine impurity C | 79088-29-2 | C17H19ClF3NO |
| Fluoxetine impurity C | 79088-29-2 | C17H19ClF3NO |
| Fluoxetine Related Compound A | 79088-29-2 | C17H19ClF3NO |
| Fluoxetine Related Compound B | 23580-89-4 | C10H15N |
| Fluoxetine Related Compound C | 1026723-45-4 | C21H22F3NO4 |
| Fluoxetine-d5 Hydrochloride | 1173020-43-3 | C17H19ClF3NO |
| Flupentixol Decanoate Imp. B (BP): 2-Trifluoromethyl- thioxanthone | 1693-28-3 | C14H7F3OS |
| Flupentixol Dihydrochloride Imp. G (EP): 2-(Trifluoromethyl)-9H- thioxanthen-9-one (2-Trifluoromethyl- thioxanthone) | 1693-28-3 | C14H7F3OS |
| Flupentixol EP Impurity A | Not available | C19H20F3NOS |
| Flupentixol EP Impurity B | 47346-96-3 | C19H18F3NS |
| Flupentixol EP Impurity F | Not available | C23H25F3N2OS |
| Flupentixol EP Impurity G | 1693-28-3 | C14H7F3OS |
| Flupentixol EP Impurity H | Not available | C23H25F3N2OS |
| Flupentixol for system suitability | 2709-56-0 | C23H25F3N2OS |
| Flupentixol impurity D | 791521-96-5 | C25H29F3N2O2S |
| Flupentixol impurity D | Not available | C25H29F3N2O2S |
| Flupentixol N1-Oxide | Not available | C23H25F3N2O2S |
| Fluphenazine | 69-23-8 | C22H26F3N3OS |
| Fluphenazine Decanoate N4-Oxide | 76005-64-6 | C32H44F3N3O3S |
| Fluphenazine Dihydrochloride Imp. A (EP): 2-[4-[3-[5-Oxo-2-(trifluoromethyl)- 10H-5 4-phenothiazin-10-yl]propyl]piperazin-1- yl]ethanol (Fluphenazine S-Oxide) | 1674-76-6 | C22H26F3N3O2S |
| Fluphenazine Dihydrochloride Imp. D (EP): 10,10'-[Piperazine-1,4-diylbis(propane- | 2376-89-8 | C36H34F6N4S2 |
| Fluphenazine Dihydrochloride Imp. E (EP): 2-[4-[3-[2-Chloro-10H-phenothiazin- | 58-39-9 | C21H26ClN3OS |
| Fluphenazine EP impurity A | 1674-76-6 | C22H26F3N3O2S |
| Fluphenazine EP impurity B | 1476-79-5 | C22H26F3N3O3S |
| Fluphenazine impurity 1 | 97671-70-0 | C30H40F3N3O2S |
| Fluphenazine impurity 2 | 343-20-4 | C13H8F3NS |
| Fluphenazine impurity 3 | 397-50-2 | C13H8F3NS |
| Fluphenazine impurity 4 | 76005-60-2 | C22H26F3N3O3S |
| Fluphenazine impurity 5 | 30897-25-7 | C22H26F3N3O2S |
| Fluphenazine N1-Oxide Dihydrochloride | Not available | C22H28Cl2F3N3O2S |
| Fluphenazine N1-Oxide Dihydrochloride | 2724689-70-5 | C22H28Cl2F3N3O2S |
| Fluphenazine N4'-oxide | 30897-25-7 | C15H11I4NO4 |
| Fluphenazine N,N',S-Trioxide Dihydrochloride | 2732347-04-3 | C22H28Cl2F3N3O4S |
| Fluphenazine N,N',S-Trioxide Dihydrochloride | Not available | C22H28Cl2F3N3O4S |
| Fluphenazine N,N',S-Trioxide Dihydrochloride | 76005-63-5 | C22H28Cl2F3N3O4S |
| Fluphenazine octanoate | 5002-47-1 | C32H44F3N3O2S |
| Fluphenazine Sulfone | 1476-79-5 | C22H26F3N3O3S |
| Fluphenazine Sulfone N1,N4-Dioxide | 86137-45-3 | C22H26F3N3O5S |
| Fluphenazine Sulfone N1,N4-Dioxide (Fluphenazine N1,N4,S,S-Tetraoxide) | 86137-45-3 | C22H26F3N3O5S |
| Fluphenazine sulfoxide | 1674-76-6 | C22H26F3N3O2S |
| Fluphenazine sulfoxide | 1674-76-6 | C22H26F3N3O2S |
| Flupirtine Impurity 1 | 1417916-52-9 | C30H32F2N8O4 |
| Fluralaner Impurity 2 | 861555-67-1 | C9H10O3 |
| Fluralaner Impurity 4 | 2382920-52-5 | C13H14F3N3O3 |
| Fluralaner Impurity 5 | 2382920-54-7 | C13H13ClF3N3O3 |
| Fluralaner-001 | 55860-35-0 | C10H10O3 |
| Fluralaner-002 | 130336-16-2 | C8H3Cl2F3O |
| Fluralaner-003 | 37074-40-1 | C9H9BrO |
| Fluralaner-004 | 40180-80-1 | C9H9BrO |
| Fluralaner-005 | 944268-58-0 | C9H9BrO |
| Fluralaner-006 | 52779-76-7 | C9H9BrO |
| Fluralaner-009 | 591-35-5 | C6H4Cl2O |
| Fluralaner-010 | 19752-55-7 | C6H3BrCl2 |
| Fluralaner-011 | 1036715-60-2 | C11H12O3 |
| Fluralaner-013 | 160313-69-9 | C10H11BrO2 |
| Fluralaner-014 | 359821-38-8 | C4H7F3N2O |
| Fluralaner-014 HCl | 1171331-39-7 | C4H8ClF3N2O |
| Fluralaner-015 | 1164268-79-4 | C22H20Cl2F3NO3 |
| Fluralaner-016 | 1564638-18-1 | C8H6Br2O2 |
| Fluralaner-017 | 7697-28-1 | C8H7BrO2 |
| Fluralaner-019 | 1095275-07-2 | C18H13Cl2F3O4 |
| Fluralaner-019-EYA | 1095275-09-4 | C22H24Cl2F3NO4 |
| Fluralaner-019-SYA | 1095275-08-3 | C24H28Cl2F3NO4 |
| Fluralaner-020 | 170230-01-0 | C10H12BrNO2 |
| Fluralaner-021 | 943436-51-9 | C17H12BrCl2F3O2 |
| Fluralaner-022 | 943437-03-4 | C17H10BrCl2F3O |
| Fluralaner-023 | 864725-60-0 | C17H11BrCl2F3NO |
| Fluralaner-024 | 864725-62-2 | C18H12Cl2F3NO3 |
| Fluralaner-025 | 5156-01-4 | C9H8O4 |
| Fluralaner-026 | 1857027-20-3 | C12H15BrO2 |
| Fluralaner-027 | 3113-71-1 | C8H7NO4 |
| Fluralaner-028 | 5437-38-7 | C8H7NO4 |
| Fluralaner-029 | 3113-72-2 | C8H7NO4 |
| Fluralaner-030 | 53663-39-1 | C8H7BrO2 |
| Fluralaner-031 | 6967-82-4 | C8H7BrO2 |
| Fluralaner-032 | 2941-78-8 | C8H9NO2 |
| Fluralaner-033 | 4389-45-1 | C8H9NO2 |
| Fluralaner-034 | 2486-70-6 | C8H9NO2 |
| Fluralaner-035 | 864736-32-3 | C19H14Cl2F3NO3 |
| Fluralaner-036 | 864725-61-1 | C20H16Cl2F3NO3 |
| Fluralaner-037 | 503470-23-3 | C9H8O3 |
| Fluralaner-038 | 68837-59-2 | C8H7BrO2 |
| Fluralaner-041 | 864725-22-4 | C9H5Cl2F3 |
| Fluralaner-042 | 864731-37-3 | C20H15Cl2F3N2O4 |
| Fluralaner-045 | 14862-52-3 | C6H3Br2Cl |
| Fluralaner-046 | 1655515-91-5 | C8H3BrClF3O |
| Fluralaner-048 | 864730-61-0 | C20H14Cl2F6N2O2 |
| Flurandrenolide | 1524-88-5 | C24H33FO6 |
| Flurandrenolone acetate | 2802-11-1 | C26H35FO7 |
| Flurazepam Related Compound C | 19347-55-8 | C19H23Cl2FN2O |
| Flurbiprofen 1,2,3-Propanetriol Esters (Mixture of Regio- and Stereoisomers) | Not available | C36H38F2O8 |
| Flurbiprofen 1,2-Propylene Glycol Esters (Mixture of Regio- and Stereoisomers) | Not available | C36H38F2O6 |
| Flurbiprofen 1,3-Butylene Glycol Esters (Mixture of Regio- and Stereoisomers) | Not available | C38H42F2O6 |
| Flurbiprofen 2,3-Butylene Glycol Ester | Not available | C19H21FO3 |
| Flurbiprofen EP Impurity B | 1797883-74-9 | C18H17FO4 |
| Flurbiprofen EP Impurity C | 61466-95-3 | C15H13FO3 |
| Flurbiprofen EP Impurity H | 66202-86-6 | C16H15FO2 |
| Flurbiprofen EP Impurity J | 42771-82-4 | C16H13FO4 |
| Flurbiprofen EP Impurity M | 119623-42-6 | C19H19FO4 |
| Flurbiprofen Ethyl Ester | 64858-90-8 | C17H17FO2 |
| Flurbiprofen for peak identification | 5104-49-4 | C15H13FO2 |
| Flurbiprofen Imp. A (EP): (2RS)-2-(Biphenyl-4-yl)propanoic Acid | 6341-72-6 | C15H14O2 |
| Flurbiprofen Imp. C (EP): (2RS)-2-(2-Fluorobiphenyl-4-yl)- 2-hydroxypropanoic Acid | 61466-95-3 | C15H13FO3 |
| Flurbiprofen Impurity 1 | 55258-76-9 | C14H13F |
| Flurbiprofen Impurity 2 | 52807-12-2 | C15H13FO3 |
| Flurbiprofen Impurity 3 | 64858-90-8 | C17H17FO2 |
| Flurbiprofen Impurity 4 | 1685278-08-3 | C19H20O4 |
| Flurbiprofen Impurity 7 | 75-99-0 | C3H4Cl2O2 |
| Flurbiprofen Impurity 8 | 91503-88-7 | C19H19FO4 |
| Flurbiprofen Impurity 10 | 91503-79-6 | C19H19FO4 |
| Flurbiprofen Impurity 14 | 908559-44-4 | C25H31FO2 |
| Flurbiprofen Impurity 17 | 1206101-29-2 | C24H16F2 |
| Flurbiprofen Impurity 18 | 66067-41-2 | C15H13FO4 |
| Flurbiprofen Impurity 19 | 124097-43-4 | C15H13FO3 |
| Flurbiprofen Impurity 20 | 124635-84-3 | C18H19FO4 |
| Flurbiprofen Impurity 20 | 41635-83-0 | C16H15FO3 |
| Flurbiprofen Impurity 21 | 124635-86-5 | C18H19FO4 |
| Flurbiprofen Impurity 22 | 87657-78-1 | C15H14FNO |
| Flurbiprofen Impurity 22 | 1346604-78-1 | C16H15FO4 |
| Flurbiprofen Impurity 23 | 399-31-5 | C8H8FNO |
| Flurbiprofen Impurity 23 | 74648-00-3 | C15H12FN |
| Flurbiprofen Impurity 24 | 446-35-5 | C6H3F2NO2 |
